There were no significant changes in AST, ALT, or creatinine levels among the tumor-bearing mice receiving VSV-S, αPD1, or their combination (Fig. 7H), suggesting that neither the single agent nor their combination caused hepatotoxicity or nephrotoxicity. Here, GPT is linked to neoplasm.